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Abstract Although plasmalogens are the predominant phos- 
pholipids of cardiac sarcolemma, their physiological role has not 
been forthcoming. Since the cardiac sarcolemmal sodium- 
calcium exchanger has been proposed to be regulated by anionic 
phospholipids, the roles of plasmalogens and anionic phospho- 
lipids as regulators of the sodium-calcium exchanger were 
explored. Reconstituted sodium-calcium exchange activity in 
plasmalogen-containing proteoliposomes was 10-fold higher than 
that in control proteoliposomes comprised of only diacyl 
phospholipids. Additionally, exchange activity in plasmalogen- 
containing proteoliposomes was regulated by anionic phospho- 
lipids. Thus, plasmalogens provide a critical lipid environment in 
which anionic phospholipids serve as boundary lipids for the 
regulation of the trans-sarcolemmal sodium-calcium exchanger. 
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I. Introduction 
Plasmalogens are a phospholipid molecular subclass con- 
taining a vinyl ether bond that links the sn-1 aliphatic chain 
to the glycerol backbone and are the predominant phospho- 
lipids found in the sarcolemma of myocardium [1]. In com- 
parison to diacyl phospholipids, plasmalogens have unique 
membrane biophysical properties [2,3], have a greater propen- 
sity to facilitate membrane fusion [4], and are selectively hy- 
drolyzed during myocardial ischemia [5-7]. Although the bio- 
chemical and biophysical differences between plasmalogens 
have been identified, the physiological importance of plasma- 
logens in cardiac sarcolemma remains unresolved. One possi- 
ble physiological role of sarcolemmal plasmalogens i  the reg- 
ulation of sarcolemmal transmembrane proteins that are 
responsible for normal myocytic intracellular ion homeostasis. 
Accordingly, to delineate the role of plasmalogens on sarco- 
lemmal transmembrane protein function, we now report that 
cardiac sarcolemmal plasmalogens are important regulators of 
sodium-calcium exchange activity and participate in the reg- 
ulation of sodium-calcium exchange activity by anionic phos- 
pholipids which serve as boundary lipids. 
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Abbreviations." FMOC, 9-fluorenylmethoxy-carbonyl; GPC, sn-gly- 
cero-3-phosphocholine; GPE, sn-glycero-3-phosphoethanolamine; 
GPFE, sn-glycero-3-N-FMOC-phosphoethanolamine; 16:0-18:1 plas- 
menylcholine, 1 - O-hexadec- l' enyl-2-octadec-9'-enoyl-GPC; 16:0- 
20:4 phosphatidylethanolamine, l-hexadecanoyl-2-eicosatetra- 
5',8', 11 ', 14'-enoyl-GPE; 16: 0-18:1 phosphatidylcholine, 1 -hexadeca- 
noyl-2-octadec-9'-enoyl-GPC 
2. Materials and methods 
2.1. Synthesis and purification of plasmenylcholine and 
plasmenylethanolamine 
Plasmenylcholine was synthetically prepared and HPLC-purified as 
previously described [8] by an anhydrous reaction utilizing 1-O-hex- 
adec-l'-enyl-GPC (120 mg) and octadec-9'-enoyl chloride (300 rag) as 
precursors and dimethylaminopyridine (100 rag) as catalyst. The pur- 
ity of the synthetically prepared 16:0-18:1 plasmenylcholine was de- 
termined to be greater than 99% by reversed-phase HPLC, straight- 
phase HPLC and capillary gas chromatography of the aliphatic on- 
stituents. Capillary gas chromatography was also used to quantitate 
16:0-18:1 plasmenylcholine. 
Plasmenylethanolamine was synthesized utilizing similar strategies 
to that used for the preparation of plasmenylcholine with the excep- 
tion that the ethanolamine h ad group of lysoplasmenylethanolamine 
was protected with FMOC and deprotected prior to and following, 
respectively, the acylation of l-O-hexadec-l'-enyl-GPE with eicosate- 
tra-5',8',ll',14'-enoyl chloride. Briefly, lysoplasmenylethanolamine 
was prepared by base methanolysis of 2 g of bovine heart ethanol- 
amine glycerophospholipids and was purified by preparative straight- 
phase HPLC utilizing a Dynamax-Si column (total column dimen- 
sions: 21 mmx600 mm) and a linear gradient over 90 min from 
chloroform to methanol at 10 ml/min (HPLC System I). Next the 
ethanolamine head group of lysoplasmenylethanolamine was pro- 
tected with FMOC by mixing 240 mg lysoplasmenylethanolamine 
and 540 mg FMOC in 20 ml of anhydrous, distilled chloroform for 
2 h at 40°C. The FMOC-protected mixture of lysoplasmenylethanol- 
amines was extracted into chloroform prior to the purification of l-O- 
hexadec-l'-enyl-GPFE by HPLC utilizing an Alltech C18 column 
(10 mmx250 mm, 10 gin particle size) and isocratic elution with a 
mobile phase comprised of methanol/acetonitrile/water (57123120, v/v/ 
v) containing 20 mM choline chloride at a flow rate of 9 ml/min. 
FMOC-protected 1-O-hexadec- 1 '-enyl-2-eicosatetra-5',8', 11 ', 14'-eno- 
yl-GPE was then prepared by mixing 40 mg l-O-hexadec-l'-enyl- 
GPFE, 100 mg eicosatetra-5',8',l l',14'-enoyl chloride and 47 mg di- 
methylaminopyridine i  50 ml of anhydrous, redistilled chloroform at 
35°C for 3 h. The reaction was terminated with the addition of 2 
volumes of water/methanol (l/l, v/v) and the product, l-O-hexadec- 
l'-enyl-2-eicosatetra-5',8',l l',14'-enoyl-GPFE, was collected in the 
chloroform phase. Deprotection of l-O-hexadec-l'-enyl-2-eicosate- 
tra-5',8',ll',14'-enoyl-GPFE in 1.5 ml of chloroform was initiated 
by the addition of 1.5 ml of diethylamine and the deprotection reac- 
tion was stirred under nitrogen for 2 h at room temperature, Depro- 
tection was continued for another 2 h with 1 ml of additional diethyl- 
amine added. Deprotection was terminated by extraction with 
methanol and water added to form a counterphase~ Straight-phase 
HPLC System I was utilized to purify 16:0-20:4 plasmenylethanol- 
amine followed by further HPLC purification with the same prepara- 
tive HPLC column but with a mobile phase comprised of hexane/ 
isopropanollO.O05% ammonia hydroxide in water with a gradient 
from a mobile phase composition of 48.5148.513 to 46.5146.5/7. The 
purity of the synthetically prepared 16:0-20:4 plasmenylethanolamine 
was then determined to be greater than 99°/; by reversed-phase HPLC, 
straight-phase HPLC and capillary gas chromatography of the ali- 
phatic constituents. Capillary gas chromatography was also used to 
quantitate 16:0-20:4 plasmenylethanolamine. 
2.2. Preparation of cardiac sarcolemmal vesicles 
Cardiac sarcolemmal vesicles were prepared from bovine ventricu- 
lar tissue as described by Slaughter et al. [9] and modified by Shannon 
0014-5793196/$12.00 ~© 1996 Federation of European Biochemical Societies. All rights reserved. 
PH S00 1 4 -5793(96)00930-  1 
100 D.A. Ford, C.C. Hale/FEBS Letters 394 (1996) 99-102 
et al. [10]. The final sarcolemma vesicle preparation was resuspended 
in 160 mM NaC1, 20 mM MOPS/TRIS, pH 7.4 and stored at -70°C. 
2.3. Reconstitution f cardiac sodium-calcium exchange activity 
Sodium-calcium exchange activity was reconstituted from cardiac 
sarcolemmal vesicles and assayed as described by Hale et al. [11]. All 
experiments were performed in triplicate with 1 3 different bovine 
cardiac sarcolemmal vesicle preparations. In some experiments, the 
exchange inhibitory peptide (XIP) was used to inhibit sodium-calcium 
exchange activity as previously reported [12]. 
2.4. Miscellaneous a says 
Bovine cardiac sarcolemmal vesicle protein content was determined 
by the method of Lowry et al. [13]. Reconstituted proteoliposome 
protein content was determined by the method of Schaffner and Weis- 
mann [14] as described by Hale et al. [1 l]. 
3. Results 
3.1. Reconstitution fcardiac sodium-calcium exchange activity 
in proteoliposomes containing plasmalogens 
Since plasmalogens are the major molecular subclass but 
not the exclusive molecular subclass of phospholipids present 
in mammalian cardiac myocyte sarcolemma [1], the effect of 
plasmalogens on sodium-calcium exchange activity in recon- 
stituted proteoliposomes was compared to that of diacyl phos- 
pholipids. Previous attempts to reconstitute sodium-calcium 
exchange activity with diacyl phospholipids in the absence 
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Fig. 1. Sodium-calcium exchange reconstitution experiments with 
plasmalogen and diacyl phospholipids. Bovine cardiac sarcolemmal 
vesicle proteins were extracted with sodium cholate. Solubilized vesi- 
cle proteins were reconstituted with selected exogenous phospholip- 
ids by the detergent dilution method with the final protein/phospho- 
lipid ratio being 2 mg vesicle protein/25 mg phospholipid. Sodium- 
calcium exchange activity was quantified as described in Section 2. 
Sodium-calcium exchange activity was measured as the difference of 
4~Ca vesicular uptake in the presence or absence of an outwardly di- 
rected sodium gradient. The phospholipid composition of proteo- 
liposomes (in mol percent) were as follows for each condition: con- 
dition I=16:0-18:1 phosphatidylcholine (50), 16:0-20:4 phos- 
phatidylethanolamine (40), phosphatidylserine (5), and cholesterol 
(5); condition II = 16:0-18:1 plasmenylcholine (30), 16:0-20.4 plas- 
menylethanolamine (30), 16:0-18:1 phosphatidylcholine (30), and 
16:0-20:4 phosphatidylethanolamine (10);and condition III= 16:0- 
18:1 plasmenylcholine (25), 16:0-20:4 plasmenylethanolamine (30),
16:0-18:1 phosphatidylcholine (25), 16:0-20:4 phosphatidyl- 
ethanolamine (I0), phosphatidylserine (5), and cholesterol (5). For 
condition IV, sodium-calcium exchange activity was quantified in 
native bovine sarcolemmal vesicles. Values for sodium-calcium ex- 
change activity are the mean+ S.E.M. for three independent meas- 
urements. 
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Fig. 2. Inhibition of sodium-calcium exchange activity in reconsti- 
tuted proteoliposomes by the exchange inhibitory peptide (XIP). So- 
dium-calcium exchange activity was reconstituted into proteolipo- 
somes as described in Section 2. Sodium-calcium exchange activity 
was measured in the presence and absence of 5 taM XIP (RRLLFY- 
KYVYRYRAGKQRG) [12]. XIP was present only during the 
transport assay period (3 s). The proteoliposome phospholipid com- 
position was (in mol%): condition I = 16:0-18:1 phosphatidylcholine 
(50), 16:0-20:4 phosphatidylethanolamine (40), phosphatidylserine 
(5), and cholesterol (5); condition II= 16:0-18:1 plasmenylcholine 
(30), 16:0-20:4 plasmenylethanolamine (30),16:0-18:1 phosphatidyl- 
choline (30), and 16:0-20:4 phosphatidylethanolamine (10); and 
condition III= 16:0-18:1 plasmenylcholine (25), 16:0-20:4 plasmenyl- 
ethanolamine (30), 16:0-18:1 phosphatidylcholine (25), 16:0-20:4 
phosphatidylethanolamine (10), phosphatidylserine (5), and choles- 
terol (5). For condition IV, sodium-calcium exchange activity was 
quantified in native bovine sarcolemmal vesicles. Values of sodium- 
calcium exchange inhibition are from three measurements under 
each condition. 
of negatively charged phospholipids (e.g. phosphatidylserine) 
were unsuccessful [10]. However, reconstitutions with diacyl 
phospholipids (e.g. 16:0-18:1 phosphatidylcholine and 16:0- 
20:4 phosphatidylethanolamine) in the presence of cholesterol 
and phosphatidylserine resulted in the reconstitution of lim- 
ited sodium-calcium exchange activity (Fig. 1, condition I). In 
contrast, reconstitutions of sarcolemmal proteins in the pres- 
ence of the plasmalogens, 16:0-18:1 plasmenylcholine and 
16:0-20:4 plasmenylethanolamine, withthe diacyl phospholip- 
ids, 16:0-18:1 phosphatidylcholine and 16:0-20:4 phosphatid- 
ylethanolamine, in the absence of cholesterol and phospha- 
tidylserine resulted in the reconstitution of significantly more 
sodium-calcium exchange activity which was greater than that 
observed with diacyl phospholipids even in the presence of 
cholesterol and phosphatidylserine (e.g. Fig. 1, conditions II 
vs. I). Also, sodium-calcium exchange activity quadrupled by 
adding phosphatidylserine and cholesterol to the mixture of 
diacyl and plasmalogen phospholipids in the reconstitution 
system (Fig. 1, conditions III vs. I). It is important o note 
that condition III of Fig. 1 corresponds to the tool percent 
composition of plasmalogens, diacyl phospholipids and phos- 
phatidylserine that is similar to that found in canine sarco- 
lemma [1] and the resultant reconstituted activity approaches 
that of native bovine sarcolemma (e.g. Fig. 1, conditions III 
vs. IV). To confirm that the vesicular 4~Ca accumulation ob- 
served in proteoliposomes comprised of mixtures of plasmalo- 
gen and diacyl phospholipids hown in Fig. 1 was indeed a 
result of sodium-calcium exchange activity, we measured the 
ability of XIP to inhibit the exchange process [12]. As shown 
in Fig. 2, XIP inhibited reconstituted sodium-calcium ex- 
change activity in all proteoliposomes, including those proteo- 
D.A. Ford, C.C. HalelFEBS Letters 394 (1996) 99-102 101 
25] 
2.0 
"~ 1.5 
c~ 
Z 
0.5 
0 
95/0 55/35* 47.5/47.5 0/95 
Plasmalogen/Dlacyl (mol%/mol%) 
Fig. 3. Sodium-calcium exchange activity in reconstituted proteolip- 
osomes as a function of the plasmalogen/diacyl phospholipid ratio. 
Sarcolemmal proteins were reconstituted into proteoliposomes, and 
sodium-calcium exchange activity was measured as described in Sec- 
tion 2. All proteoliposomes contained 5 mol% phosphatidylserine 
(PS). The ratios of plasmalogerddiacyl are shown on the x-axis and 
are expressed as mol% plasmalogen/mol% diacyl phospholipid. Plas- 
malogens in these experiments included 55% 16:0-18:1 plasmenyl- 
choline and 45% 16:0-20:4 plasmeny|ethanolamine. Diacyl phos- 
pholipids in these experiments included 55% 16:0-18:1 
phosphatidylcholine and 45% 16:0-20:4 phosphatidylethanolamine. 
The asterisk indicates 5 mol% cholesterol present in addition to 
5 mol% phosphatidylserine and indicated plasmalogen and diacyl 
phospholipids. Values are the means+S.E.M, for three measure- 
ments. 
liposomes containing both plasmalogen and diacyl molecular 
subclasses of phospholipids as well as those containing diacyl 
phospholipids alone. Under all conditions, partial inhibition 
was observed by XIP since reconstitutions result in both right- 
side-in and inside-out incorporation of the sodium-calcium 
exchanger protein and since the XIP inhibitory peptide inhib- 
its only at the cytoplasmic side of the exchanger [12]. 
3.2. Sodium-calcium exchange activity in proteoliposomes a a 
function of plasmalogen content 
The role of plasmalogens a  lipid activators of sodium-cal- 
cium exchange was further explored by reconstituting the so- 
dium-calcium exchanger in vesicles comprised of different mol 
percents of diacyl and plasmalogen subclasses of phospholip- 
ids. Reconstitutions in these experiments contained 5 mol% 
phosphatidylserine (with the remaining phospholipid compris- 
ing 95 mol% of the lipid expressed as plasmalogen/diacyl 
phospholipid proteoliposome content). These experiments 
clearly demonstrated that reconstituted sodium-calcium ex- 
change activity increased as the ratio of plasmalogen to diacyl 
molecular subclasses of phospholipids increased (Fig. 3). 
When comparing the extremes (i.e. 95/0 versus 0/95), recon- 
stitution in plasmalogen-enriched proteoliposomes yielded a 
greater than 10-fold enhancement in reconstituted sodium-cal- 
cium exchange activity. Taken together, these data show that 
plasmalogens are important phospholipid regulators of the 
sarcolemmal sodium-calcium exchanger and demonstrate for 
the first time that plasmalogens are critical membrane phos- 
pholipids that can have profound effects on endogenous plas- 
ma membrane proteins. 
3.3. Phosphatidylserine r gulates odium-calcium exchange 
activity in plasmalogen vesicles 
The previous demonstration that anionic phospholipids en- 
hance sodium-calcium exchange [10,15] has led to a model of 
phospholipid regulation of sodium-calcium exchange which 
includes a neutral ipid bilayer containing microenvironments 
enriched with anionic phospholipids that interact with the 
positively charged XIP domain of the exchanger protein 
[10]. Accordingly, we examined the effect of phosphatidylser- 
ine in proteoliposomes containing plasmalogens in the ab- 
sence of diacyl phospholipids. The addition of phosphatidyl- 
serine (5 mol%) to plasmalogen vesicles enhanced the 
observed sodium-calcium exchange activity nearly 2-fold 
(Fig. 4). Thus, the presence of phosphatidylserine appears to 
enhance sodium-calcium exchange activity irrespective of the 
molecular subclass of the neutral phospholipid. Additionally, 
reconstitutions in vesicles comprised of plasmalogens and 
phosphatidylserine enhanced sodium-calcium exchange nearly 
6-fold over that in vesicles comprised of diacyl phospholipids 
and phosphatidylserine (Fig. 4). It should also be noted that 
data in Fig. 1 demonstrate hat phosphatidylserine and chol- 
esterol enhance the activity in the presence of mixtures of 
diacyl and plasmalogen phospholipids. 
4. Discussion 
The sodium-calcium exchanger is predominantly found in 
the plasma membrane of excitatory cells and is a critical com- 
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Fig. 4. The effect of phosphatidylserine on reconstituted cardiac so- 
dium-calcium exchange activity. Sodium-calcium exchange activity 
was reconstituted into proteoliposomes with selected concentrations 
of phospholipids and quantified as described in Section 2. The pro- 
teoliposome phospholipid composition was (in tool%): plasmalo- 
gen= 16:0-18.1 plasmenylcholine (60) and 16:0-20:4 plasmenyletha- 
nolamine (40); plasmalogen + PS = 16:0-18:1 plasmenylcholine (55), 
16:0-20:4 plasmenylethanolamine (40) and phosphatidylserine (5); 
diacyl-- 100% phosphatidylcholine (from [10]); and diacyl+PS = 16:0- 
18:1 phosphatidylcholine (55), 16:0-20:4 phosphatidylethanolamine 
(40), and phosphatidylserine (5). 
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ponent of excitation-secretion as well as excitation-contraction 
coupling in these cells. Plasmalogens are the predominant 
phospholipids found in cardiac sarcolemma nd have been 
proposed to have a role in myocytic ion homeostasis [16]. 
Although plasmalogens are the major phospholipid found in 
cardiac sarcolemma and the sodium-calcium exchanger is en- 
riched in the sarcolemma, the cardiac sarcolemmal sodium- 
calcium exchanger has been previously reconstituted exclu- 
sively with diacyl phospholipids (e.g. [10,15]). The present 
results clearly demonstrate the preferential reconstitution of 
the sodium-calcium exchanger in phospholipid vesicles com- 
prised of plasmalogens as compared to diacyl phospholipids 
and underscore the importance of plasmalogens in the regula- 
tion of endogenous plasma membrane protein function. 
The demonstration that phosphatidylserine increases o- 
dium-calcium exchange activity in plasmalogen vesicles sup- 
ports and extends the model of regulation of sodium-calcium 
exchange activity by membrane phospholipids proposed by 
Hale and coworkers [10]. This expanded model includes anio- 
nic phospholipids ( uch as phosphatidylserine) in the presence 
of neutral diacyl or plasmalogen phospholipids erving as 
boundary lipids that promote a more active conformation of 
the exchange protein through interactions with the cationic 
XIP site. Furthermore, the enhanced sodium-calcium ex- 
change activity in proteoliposomes comprised of plasmalogens 
and phosphatidylserine as compared to diacyl phospholipids 
and phosphatidylserine suggests that the biophysical confor- 
mation of plasmalogen vesicles provides an enhancement of 
sodium-calcium exchange activity either directly or indirectly 
through alterations in anionic phospholipid membrane dy- 
namics in plasmalogen vesicles. 
In the present study, we evaluated the ability of selected 
lipids (i.e. plasmalogens, diacyl phospholipids, and anionic 
phospholipids) to modulate cardiac sodium-calcium exchange 
activity. An important issue that remains unanswered is the 
role of the lipid environment specifically on the transported 
substrate ions. Mechanistically, it is possible that alterations 
in the phospholipid membrane nvironment changes ubstrate 
affinity perhaps via conformational terations or even direct 
involvement with the substrate binding site. Unfortunately, 
current yields of synthetic plasmalogens are not amenable to 
producing sufficient reconstituted proteoliposomes for such 
experiments, This issue may be better addressed using electro- 
physiological techniques. 
The role of membrane lipids in the modulation of trans- 
membrane protein function is well established [17-19]. It has 
been suggested that one role of plasmalogens is in the regula- 
tion of intracellular ion homeostasis [16]. However, the role of 
plasmalogens in critical subcellular membrane pools has not 
been established. The results herein suggest hat endogenous 
sarcolemmal plasmalogens have a critical role in the regula- 
tion of sarcolemmal sodium-calcium exchange. Furthermore, 
changes in the composition of other phospholipids (e.g. anio- 
nic phospholipids) in plasmalogen-based membrane pools 
could have profound effects on sodium-calcium exchange. Ad- 
ditionally, since plasmalogens are selectively hydrolyzed ur- 
ing myocardial ischemia [5-7], it is possible that alterations in 
sarcolemmal plasmalogen content during ischemia may con- 
tribute to ischemia-induced alterations in calcium metabolism 
[20] through effects on sarcolemmal sodium-calcium exchange. 
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